when will glp 1 drugs get cheaper What Trump's GLP-1 deal means for workplace coverage Patients Face New Barriers for

So far, Novo is furthest ahead in developing an obesity pill

10.1167/iovs.09-5103

One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition

Weight loss improves metabolic markers, but the cellular machinery for processing energy, meaning mitochondrial function, may need separate support, particularly in individuals with long-standing metabolic dysfunction

Its therapeutic potential, as extensively reviewed by Nauck et al

doi: 10.1038/s41591-024-03412-w